QQ客服 官方微博 反馈留言

	Phase 3 Trial of Whole Brain Radiotherapy with Concurrent Erlotinib Versus WBRT Alone for NSCLC with Brain Metastases (ENTER)
	Yang, Z.; Zhang, Y.; Li, R.; Yisikandaer, A.; Ren, B.; Sun, J.; Li, J.; Chen, L.; Zhao, R.; Zhang, J.
刊名	JOURNAL OF THORACIC ONCOLOGY
	2018
卷号	13期号:10
关键词	EGFR-TKI Brain metastasis WBRT
ISSN号	1556-0864
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3414684
专题	昆明医科大学
推荐引用方式 GB/T 7714	Yang, Z.,Zhang, Y.,Li, R.,et al. Phase 3 Trial of Whole Brain Radiotherapy with Concurrent Erlotinib Versus WBRT Alone for NSCLC with Brain Metastases (ENTER)[J]. JOURNAL OF THORACIC ONCOLOGY,2018,13(10).
APA	Yang, Z..,Zhang, Y..,Li, R..,Yisikandaer, A..,Ren, B..,...&Zhang, J..(2018).Phase 3 Trial of Whole Brain Radiotherapy with Concurrent Erlotinib Versus WBRT Alone for NSCLC with Brain Metastases (ENTER).JOURNAL OF THORACIC ONCOLOGY,13(10).
MLA	Yang, Z.,et al."Phase 3 Trial of Whole Brain Radiotherapy with Concurrent Erlotinib Versus WBRT Alone for NSCLC with Brain Metastases (ENTER)".JOURNAL OF THORACIC ONCOLOGY 13.10(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。